Smart Patients Get Smart Care™
The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients
By Utkarsh Acharya, DO, FACP Dr. Acharya took amazing care of me when I had my CAR-T therapy in Seattle. He writes a more advanced article about why there is so
By Larry Saltzman – Patient My CAR T journey began in 2016. My CLL journey began in 2010 with a prognosis based on my markers of 8 years. For those first six
By Laurie Adami – Patient I am Laurie Adami and I grew up in the Northeast, moving to the Boston area when I was in high school. I attended Colgate University
During ASH 2019, our own Dr. Brian Koffman interviewed Dr. Paul Barr, Associate Professor of Medicine at the Wilmot Cancer Institute, where they discussed a new analysis of clinical trial data that looks at how effective ibrutinib is depending on when it is used in a patient’s course of therapy.
CAR-T is a revolutionary therapy in CLL and other blood cancers. As part of the team led by Dr. Carl June at U. Penn, Dr. Joe Fraietta’s translational research has taken CAR-T from an exciting possibility to a lifesaving “living drug”. Don’t miss this opportunity to be able to learn about the latest CAR-T research and to ask your questions of one of CAR-T’s most innovative pioneers.
iwCLL 2019: Dr. David Maloney on targeted agents, transplants, and CAR-T therapy for treating chronic lymphocytic leukemia (CLL)
Recorded Saturday, October 10, 2020 Flash Session 2: Clinical Trials https://youtu.be/JJP_JWQODkE CLL Society Resources Download Slides Audience Questions Agenda About CLL Society Sign up for CLL Society’s This Week emails
Recorded Saturday, October 10, 2020 Welcome and Introductions SPEAKERPatricia KoffmanCo-Founder and Communications DirectorCLL Society Click to play Session 1: Definitions, Diagnosis, Test Before Treat™ and Early Management in CLL MODERATORBrian Koffman,
By Keith Seagull – Patient Updated 10/3/2020: “I am happy to report that as of 9/30/2020 my Flow Cytometry Report has found no evidence of residual/recurrent chronic lymphocytic leukemia. That means
One click to our most popular content.
